Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
21.90
+0.95 (4.53%)
At close: Apr 28, 2026, 4:00 PM EDT
22.00
+0.10 (0.46%)
After-hours: Apr 28, 2026, 5:57 PM EDT
Alignment Healthcare Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Alignment Healthcare stock have an average target of 23.13, with a low estimate of 18 and a high estimate of 30. The average target predicts an increase of 5.62% from the current stock price of 21.90.
Analyst Consensus: Buy
* Price targets were last updated on Feb 5, 2026.
Analyst Ratings
The average analyst rating for Alignment Healthcare stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 4 | 2 |
| Buy | 5 | 6 | 6 | 6 | 6 | 4 |
| Hold | 3 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 12 | 12 | 12 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $23 → $26 | Buy | Maintains | $23 → $26 | +18.72% | Feb 5, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $19 → $25 | Strong Buy | Maintains | $19 → $25 | +14.16% | Jan 16, 2026 |
| UBS | UBS | Hold Maintains $18 → $21 | Hold | Maintains | $18 → $21 | -4.11% | Jan 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $20 → $30 | Buy | Maintains | $20 → $30 | +36.99% | Jan 6, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $20 → $23 | Buy | Maintains | $20 → $23 | +5.02% | Dec 17, 2025 |
Financial Forecast
Revenue This Year
5.28B
from 3.95B
Increased by 33.69%
Revenue Next Year
6.59B
from 5.28B
Increased by 24.74%
EPS This Year
0.13
from -0.00
EPS Next Year
0.74
from 0.13
Increased by 454.92%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.5B | 7.2B | |||
| Avg | 5.3B | 6.6B | |||
| Low | 5.0B | 6.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 38.0% | 36.5% | |||
| Avg | 33.7% | 24.7% | |||
| Low | 27.8% | 13.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.17 | 0.85 | |
| Avg | 0.13 | 0.74 | |
| Low | 0.05 | 0.65 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 536.0% | |
| Avg | - | 454.9% | |
| Low | - | 383.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.